Welcome to our dedicated page for Ingersoll-Rand SEC filings (Ticker: IR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions. These filings offer detailed information on the company’s operations, governance, and financial performance across its Industrial Technologies and Services and Precision and Science Technologies segments.
Ingersoll Rand regularly files Current Reports on Form 8-K to disclose material events. Recent 8-K filings include reports on quarterly financial results, where the company furnishes earnings press releases that discuss segment orders, revenues, Adjusted EBITDA, and guidance, as well as filings related to board changes. For example, the company has filed 8-Ks describing the appointment of new independent directors and their committee assignments, including roles on the Compensation, Sustainability, and Nominating and Corporate Governance Committees.
Through this filings page, users can also review documents that explain how Ingersoll Rand uses non-GAAP financial measures such as Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow, and Free Cash Flow Margin. The company’s disclosures describe how these metrics are calculated, why management and the board use them, and how they relate to liquidity, capital allocation, and performance evaluation.
Stock Titan enhances these regulatory documents with AI-powered summaries that help interpret key points from lengthy filings. As new IR filings are posted to EDGAR, they are updated here, allowing investors to quickly locate quarterly results, material event disclosures, and governance updates. Users interested in topics such as segment performance, capital allocation, director appointments, or the company’s use of non-GAAP metrics can use this page as a central reference for Ingersoll Rand’s official SEC reporting history.
Ingersoll Rand Inc. director William P. Donnelly reported the vesting and conversion of previously granted restricted stock units into common stock. On February 26, 2026, 3,029 restricted stock units granted on February 26, 2025 vested and were settled into 3,029 shares of common stock at no cash exercise price. Following this conversion, Donnelly directly holds 56,831 shares of Ingersoll Rand common stock.
Ingersoll Rand Inc. director Jennifer Hartsock reported the vesting and settlement of 2,429 restricted stock units on February 26, 2026. These units, originally granted on February 26, 2025, were settled into the same number of common shares at no exercise price, bringing her direct common stock holdings to 7,864 shares.
Ingersoll Rand Inc. director Mark P. Stevenson reported an equity award vesting and share issuance. On February 26, 2026, 2,309 restricted stock units granted on February 26, 2025 vested and were exercised, converting into 2,309 shares of common stock at a price of $0.00 per share. Following this derivative exercise and settlement in stock, Stevenson directly holds 11,705.552 shares of Ingersoll Rand common stock.
Ingersoll Rand Inc. director Marc Ellis Jones acquired 2,489 shares of common stock on February 26, 2026 through the vesting and settlement of an equal number of restricted stock units originally granted on February 26, 2025. Following this RSU conversion, he directly owns 26,401 common shares.
Ingersoll Rand Inc. director JoAnna Sohovich acquired shares through vesting of equity awards. On February 26, 2026, 2,429 restricted stock units granted on February 26, 2025 vested and were settled at no cost to her. This conversion produced 2,429 shares of common stock, bringing her directly owned stake to 5,427 shares.
Ingersoll Rand Inc. director John Humphrey reported an equity award vesting rather than an open‑market trade. On February 26, 2026, 2,609 restricted stock units granted on February 26, 2025 vested and were settled through the delivery of 2,609 shares of common stock at no exercise price.
Following the settlement, Humphrey directly owns 26,592 shares of Ingersoll Rand common stock. The transaction is recorded as an exercise or conversion of a derivative security, reflecting routine compensation-based share delivery rather than a discretionary share purchase or sale.
Vicente Reynal reported multiple sell transactions in the issuer's common stock across January and February
Reported trades include 191,000 shares on
Stevenson Mark P reported acquisition or exercise transactions in this Form 4 filing.
Ingersoll Rand Inc. director Mark P. Stevenson reported receiving a grant of 2,235 restricted stock units on February 23, 2026. The award was reported at a price of $0.0000 per unit, reflecting a compensation grant rather than an open-market purchase.
According to the disclosure, these 2,235 restricted stock units will vest on February 23, 2027. Upon vesting, each unit will be settled by delivery of one share of common stock, an equivalent amount of cash, or a combination of stock and cash, at the company’s election or as specified in the plan.
Swanenburg Michelle reported acquisition or exercise transactions in this Form 4 filing.
Ingersoll Rand Inc. director Michelle Swanenburg reported receiving a grant of 2,448 restricted stock units. The award was made at a stated price of $0.0000 per unit and is held as a direct ownership position.
These restricted stock units are scheduled to vest on February 23, 2027. Upon vesting, each unit will be settled in either one share of common stock, an equivalent cash amount, or a combination of stock and cash, providing future value tied to the company’s equity.
Sohovich JoAnna reported acquisition or exercise transactions in this Form 4 filing.
Ingersoll Rand Inc. director JoAnna Sohovich reported receiving a grant of 2,341 restricted stock units. These units were awarded at no cash cost to her and represent a form of equity-based compensation. The restricted stock units are scheduled to vest on February 23, 2027, and upon vesting each unit will be settled in either one share of common stock, an equivalent cash amount, or a combination of stock and cash, providing future value tied to the company’s performance.